Director, Health Economics & Outcome Research

Integra LifeSciences•Princeton, NJ

22h•$145,000 - $199,000

About The Position

Joining us is a chance to do important work that creates change and shapes the future of healthcare. Thinking differently is what we do best. To us, change equals opportunity. Every day, our colleagues are challenging what’s possible and making headway to innovate new treatment pathways to advance patient outcomes and set new standards of care. The Director, Health Economics, is a strategic leader within Global Market Access responsible for advancing the economic value proposition of Integra’s portfolio across global markets. Reporting to the Global Head of Market Access, this role shapes and executes the company’s health economics and outcomes research (HEOR) strategy to enable reimbursement, accelerate adoption, and strengthen competitive differentiation. This leader will generate and translate robust economic and real-world evidence to demonstrate the clinical, financial, and system-level value of Integra’s technologies across priority therapeutic areas, including but not limited to Surgical Reconstruction, Advanced Wound Care, Neurosurgery, ENT, Regenerative Technologies. The Director will integrate health economic theory, advanced statistical methods, epidemiology, and outcomes research to inform pricing strategy, payer engagement, coverage positioning, and portfolio optimization. Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in neurosurgery, reconstructive and general surgery, and regenerative wound care. Founded in 1989 Integra is headquartered in Princeton, New Jersey and has more than 4,000 employees worldwide.

Requirements

B.S./B.A. from an accredited university.
Master’s degree.
7 – 10 years medical device/pharmaceutical health economics or HEOR experience.
Advanced expertise in health economic modeling, including cost-effectiveness, budget impact, cost-utility, and scenario analyses.
Ability to form strong and constructive internal and external professional relationships.
Excellent collaboration skills and success working in matrix organizations at all levels.
Proactive, results-oriented, self-starter motivated by an interesting and challenging task.
Excellent written and verbal presentation communication skills.
Ability and willingness to travel domestically and internationally up to 25%.
Demonstrated experience using statistical software such as SAS, R, Stata, or Python for analysis of claims, registry, and clinical trial data.
Experience with health economic modeling platforms (e.g., TreeAge Pro) and advanced Excel-based modeling for payer-facing tools.
Working knowledge of systematic literature review, meta-analysis, and indirect treatment comparison methodologies.
Strong capability in translating complex quantitative findings into clear, payer-relevant insights and value narratives.
Familiarity with global health technology assessment (HTA) frameworks and evidence requirements across U.S. and international markets.

Nice To Haves

Doctorate in a related field.
Prior medical device industry experience.
Proficiency in statistical and econometric methodologies, including regression analysis, survival analysis, longitudinal data analysis, and real-world evidence evaluation.

Responsibilities

Develop and execute a comprehensive global health economics and outcomes research (HEOR) strategy aligned with enterprise growth priorities, reimbursement objectives, and lifecycle management plans.
Design and deliver robust economic models (cost-effectiveness, budget impact, cost-utility, and cost-consequence analyses) to quantify clinical and financial value across sites of care.
Lead the design and oversight of health economic endpoints within clinical trials and post-market studies.
Translate complex health economic and real-world evidence into clear, payer-relevant value narratives that support market access and commercial objectives.
Support development of global value dossiers, AMCP dossiers, and health technology assessment (HTA) submissions.
Support evidence generation roadmaps across priority therapeutic areas to support coverage, coding, payment, and value-based positioning.
Ensure methodological rigor through application of advanced biostatistics, epidemiology, and outcomes research methodologies.
Partner with regional Market Access leaders to inform payer engagement strategies and respond to economic evidence requirements.
Provide health economic insights to support coverage negotiations, value-based agreements, and risk-sharing arrangements.
Provide economic analyses to inform pricing strategy, reimbursement positioning, and competitive differentiation.
Support scenario modeling related to reimbursement reform, coding changes, and policy evolution.
Serve as the HEOR subject matter expert across Global Market Access, Commercial, R&D, Clinical Affairs, Medical Affairs, and Professional Education.
Integrate health economic evidence into launch planning, innovation pipelines, and early-stage product development.
Represent the company in external forums, advisory boards, and scientific congresses related to HEOR and value assessment.
Oversee publication strategy for economic and outcomes research in peer-reviewed journals and scientific meetings.
Build and maintain relationships with key academic institutions, health economists, and research partners.
Establish global HEOR standards, methodologies, and best practices across regions.
Manage external research vendors and academic collaborations to ensure high-quality and timely evidence generation.
Build scalable HEOR capabilities to support future pipeline growth and global expansion.